Faculty

Joanne Stekler

Adjunct Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Adjunct Professor, Global Health

206-744-8312
jstekler@uw.edu

Education

BA Biology, Williams College, 1992
MD Medicine (MD), Duke University, 1997
MPH Epidemiology, University of Washington, 2004

Contact

206-744-8312
jstekler@uw.edu

University of Washington
Box 359931
Division of Allergy & Infectious Diseases
Harborview Medical Center
325 Ninth Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Joanne Stekler's research centers on HIV testing and HIV prevention. She is a national expert on HIV tests, particularly focused on acute HIV infection and point-of-care testing. She started the first community-based clinic for HIV pre-exposure prophylaxis (PrEP) in Seattle and is currently working to increase access to PrEP and PrEP adherence across Washington State.

Recent Publications (PubMed)

HIV self-testing: finding its way in the prevention tool box.
(2020 Nov 30)
BMC Med 18(1): 373
Ortblad KF, Stekler JD

Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection.
(2020 Sep 22)
Cell Rep Med 1(6): 100096
Hughes SM, Levy CN, Calienes FL, Stekler JD, Pandey U, Vojtech L, Berard AR, Birse K, Noël-Romas L, Richardson B, Golden JB, Cartwright M, Collier AC, Stevens CE, Curlin ME, Holtz TH, Mugo N, Irungu E, Katabira E, Muwonge T, Lama JR, Baeten JM, Burgener A, Lingappa JR, McElrath MJ, Mackelprang R, McGowan I, Cranston RD, Cameron MJ, Hladik F

Protocol Development for HMU! (HIV Prevention for Methamphetamine Users), a Study of Peer Navigation and Text Messaging to Promote Pre-Exposure Prophylaxis Adherence and Persistence Among People Who Use Methamphetamine: Qualitative Focus Group and Interview Study.
(2020 Sep 14)
JMIR Form Res 4(9): e18118
McMahan VM, Frank N, Buckler S, Violette LR, Baeten JM, Banta-Green CJ, Barnabas RV, Simoni J, Stekler JD

Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State.
(2020 Nov 1)
Drug Alcohol Depend 216(): 108243
McMahan VM, Kingston S, Newman A, Stekler JD, Glick SN, Banta-Green CJ

Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
(2020 Aug 6)
AIDS Res Ther 17(1): 50
Bardon AR, Simoni JM, Layman LM, Stekler JD, Drain PK

Show complete publication list